Naslov
48. Trend in Consumption and Expenditure of proton Pump Inhibitors (PPIs) in 20 European Countries

Autori
Godman B, Vlahović-Palčevski V, Laius O, Bennett K, Gulbinovič J, Diogene E, paterson K, Martikainen J, Wettermark B, Gustafsson LL.

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Basic & Clinical Pharmacology and Toxicology / - , 2009, 37-37

Skup
9th Congress of the EACPT

Mjesto i datum
Edinburgh, Ujedinjeno Kraljevstvo, 12.07.2009. - 15.07.2009

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
proton pump inhibitors; consumption; cross national comparison
(pump inhibitors; consumption; cross national comparison)

Sažetak
PPI utilisation increased across all 18 countries despite effective drugs to treat h. pylori, programmes to encourage maintenance doses once healing has occurred, and concerns with prescribing for unspecified dyspepsia. Omeprazole generally dominated PPI utilisation especially following generic availability, with variable utilisation of other PPIs including esomeprazole. PPI costs (€)/ DDD decreased with increasing use of generic PPIs including generic omeprazole helping to moderate and in some cases reduce PPI expenditure. Cost/ DDD for generic omeprazole varied widely depending on for instance compulsory generic substitution, whether branded generic prescribing, and the extent of demand side initiatives. Opportunity for clinical pharmacologists and others to further improve the quality and efficiency of PPI prescribing especially given concerns and expenditure for unspecified dyspepsia.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA